Teva To Acquire Theramex in €265M Deal
Teva Pharmaceutical Industries Ltd. has reached an agreement to acquire Theramex, Merck KGaA's European women's health business, for €265 million ($369 million) cash in a bid to boost its own women's...To view the full article, register now.
Already a subscriber? Click here to view full article